Company profile
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any
- CEO
- Dr. Omid C. Farokhzad M.D., Ph.D.
- Headquarters
- Redwood City, CA, United States
- Employees
- 124
- IPO date
- Dec 4, 2020
- Sector
- Healthcare
- Industry
- Biotechnology